Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00995384
Other study ID # HIC 2009-148
Secondary ID R/C# 98699RI-09-
Status Terminated
Phase N/A
First received
Last updated
Start date October 2009
Est. completion date October 2010

Study information

Verified date March 2012
Source William Beaumont Hospitals
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the effectiveness of cardiac CT versus TEE in endocarditis patients.


Recruitment information / eligibility

Status Terminated
Enrollment 2
Est. completion date October 2010
Est. primary completion date October 2010
Accepts healthy volunteers No
Gender All
Age group 18 Years to 98 Years
Eligibility Inclusion Criteria: - Acute endocarditis with positive TEE Exclusion Criteria: - Renal failure - Contrast dye allergy - Beta-blocker allergy

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
CT Scan
Cardiac CT with special attention to valves in Endocarditis patients.

Locations

Country Name City State
United States William Beaumont Hosptial Royal Oak Michigan

Sponsors (1)

Lead Sponsor Collaborator
William Beaumont Hospitals

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Difference in CT versus TEE images in Endocarditis Upon CT Scan
Secondary Morbidity 4 weeks & 6 months post CT scan
See also
  Status Clinical Trial Phase
Recruiting NCT05547607 - Clinical and Diagnostic Features of Endocarditis
Completed NCT00750373 - Early Surgery Versus Conventional Treatment in Infective Endocarditis Phase 4
Recruiting NCT03690076 - Human Cardiac Mitochondria in Acute Endocarditis and Obesity
Terminated NCT01734694 - Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients Phase 4
Completed NCT04309591 - Cytosorb Therapy in Cardiac Surgery
Recruiting NCT05142891 - Renal Tolerance of Amoxicillin and Cloxacillin Combination
Recruiting NCT05703022 - Early Exercise Training in Patients Following Heart Valve Surgery for Infective Endocarditis. N/A
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed NCT03377465 - Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis N/A
Recruiting NCT03892174 - Cytokine REmoval in CRitically Ill pAtients Requiring Surgical Therapy for Infective Endocarditis (RECReATE) N/A
Completed NCT03695861 - Contribution of 18F-FDG PET-CT in the Diagnosis and the Detection of Peripheral Emboli of Infectious Endocarditis on Native Valves N/A
Recruiting NCT02759978 - Individualized Diagnosis of Endocarditis and Its Therapy With a Focus on Infected Prosthetic materiAL
Completed NCT00709358 - Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections Phase 4
Terminated NCT03148756 - Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis Phase 2
Enrolling by invitation NCT05156437 - Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL) Phase 4
Recruiting NCT06107309 - Suppressive Antibiotic Therapy for Endocarditis
Completed NCT02251262 - Diagnostic Accuracy of 18FDG-PET-CT for Pacing or Defibrillation Lead Infection N/A
Recruiting NCT03112356 - The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials Phase 4
Completed NCT01375257 - Partial Oral Treatment of Endocarditis Phase 4
Terminated NCT00590889 - Artificial Valve Endocarditis Reduction Trial N/A